NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028

Description

NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK

According to this report, North America’s cardiovascular ultrasound market is likely to develop with a CAGR of 5.38% in the projected duration between 2022 and 2028. The United States and Canada are analyzed in the market in this region.

Earlier, hospital admissions for cardiovascular diseases in Canada were significantly lesser. However, in recent years, hospitalizations for these ailments have risen significantly. Hospitalization rates for structural heart disease stood at 50%, and for heart failure stood at 35%. Thus, there has been a significant demand for efficient cardiovascular ultrasound systems to diagnose these illnesses in the earlier stages.

As a result, leading manufacturers are launching novel, technologically advanced products, which is expected to consolidate the market’s growth.

Heart diseases are a leading cause of death in the United States. Every year, close to 655,000 people in the country lose their lives to these ailments. Coronary heart disease (CHD) is the most common type of heart disease, which leads to nearly 366,000 deaths each year. Estimates suggest that 7.8% of adults in New York State reported having a heart attack, CHD, or stroke, in 2018.

These diseases are more common among the elderly. In the same year, 1 in every 5 New Yorkers aged 65 years or older (20%) reported being affected by some form of heart disease. The alarming prevalence of these conditions has accelerated the demand for cardiovascular ultrasound systems, which is expected to foster the market’s growth.

COMPETITIVE OUTLOOK

Leltek Inc, Telemed Ultrasound Medical Systems, Zoncare, Fujifilm Holdings Corporation, Clarius, Samsung Medison Co Ltd, Siemens Healthineers, and Esaote S.p.A. are some of the noteworthy players operating in the cardiovascular ultrasound market.

TABLE OF CONTENTS

1. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CARDIOVASCULAR ULTRASOUND MARKET
2.2. KEY INSIGHTS
2.2.1. EMERGENCE OF ARTIFICIAL INTELLIGENCE (AI)
2.2.2. STRAIN IMAGING HAS SEEN A GRADUAL INCREASE
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY IMPACT ANALYSIS
2.4.1. QUALITY
2.4.2. DURABILITY
2.4.3. PRICE
2.4.4. TECHNOLOGY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. REGULATORY FRAMEWORK
2.9. KEY MARKET STRATEGIES
2.9.1. PRODUCT LAUNCHES
2.9.2. ALLIANCES
2.10. MARKET DRIVERS
2.10.1. INCREASE IN CARDIOVASCULAR DISEASE CASES
2.10.2. ADVANCEMENTS IN TECHNOLOGY
2.11. MARKET CHALLENGES
2.11.1. LACK OF AWARENESS AMONG PATIENTS
2.11.2. NEED TO ABIDE BY STRINGENT REGULATIONS
2.12. MARKET OPPORTUNITIES
2.12.1. RAPID EXPANSION OF POINT-OF-CARE ULTRASOUND (POCUS)
2.12.2. RAPID GROWTH OF FETAL ECHOCARDIOGRAPHY
3. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY DISPLAY
3.1. BLACK AND WHITE
3.2. COLORED
4. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TECHNOLOGY
4.1. 2D
4.2. 3D/4D
4.3. DOPPLER
5. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY TYPE
5.1. TRANSTHORACIC ECHOCARDIOGRAPHY
5.2. FETAL ECHOCARDIOGRAPHY
5.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
5.4. OTHER TYPES
6. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET OUTLOOK – BY END-USER
6.1. HOSPITALS
6.2. DIAGNOSTIC CENTERS
6.3. AMBULATORY CARE CENTERS
6.4. OTHER END-USERS
7. NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET – COUNTRY OUTLOOK
7.1. UNITED STATES
7.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. GE HEALTHCARE
8.2. PHILIPS HEALTHCARE
8.3. SIEMENS HEALTHINEERS
8.4. CANON MEDICAL CORP
8.5. FUJIFILM HOLDINGS CORPORATION
8.6. SAMSUNG MEDISON CO LTD
8.7. ESAOTE S.P.A.
8.8. MINDRAY MEDICAL INTERNATIONAL LIMITED
8.9. VIATOM TECHNOLOGY CO
8.10. LANMAGE
8.11. DAWEI MEDICAL
8.12. ZONCARE
8.13. LELTEK INC
8.14. TELEMED ULTRASOUND MEDICAL SYSTEMS
8.15. CLARIUS
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ALLIANCES
TABLE 6: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, 2021 & 2028 (IN %)
FIGURE 5: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COLORED, 2022-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, 2021 & 2028 (IN %)
FIGURE 8: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, 2021 & 2028 (IN %)
FIGURE 12: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, 2021 & 2028 (IN %)
FIGURE 17: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 22: UNITED STATES CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: CANADA CARDIOVASCULAR ULTRASOUND MARKET 2022-2028 (IN $ MILLION)